Alpha 2.0
Login Register
» Articles » PMID: 6876111

Heterogeneity of Osteogenesis Imperfecta Type I

Overview
Journal J Med Genet
Specialty Genetics
Date 1983 Jun 1
PMID 6876111
Citations 9
Authors
C R Paterson
S McAllion
R Miller
Affiliations
Soon will be listed here.
Abstract

We have studied 166 patients from 71 families with Sillence type I osteogenesis imperfecta (dominant inheritance and blue sclerae). We confirm earlier findings that there are two subgroups, those with and those without dentinogenesis imperfecta; each family can be allocated to one or other group. Our confidence that the two groups represent distinct disorders is increased by finding that the patients with dentinogenesis imperfecta differ not only in their dental characteristics but also in other clinical features. They have a more severe disease with a greater fracture rate and a greater likelihood of growth impairment.

Citing Articles

Ocular characteristics and complications in patients with osteogenesis imperfecta: a systematic review.

Treurniet S, Burger P, Ghyczy E, Verbraak F, Curro-Tafili K, Micha D Acta Ophthalmol. 2021; 100(1):e16-e28.

PMID: 34009739 PMC: 9290710. DOI: 10.1111/aos.14882.

Osteogenesis imperfecta: potential therapeutic approaches.

Rousseau M, Retrouvey J PeerJ. 2018; 6:e5464.

PMID: 30128210 PMC: 6100848. DOI: 10.7717/peerj.5464.

Novel mutation of FKBP10 in a pediatric patient with osteogenesis imperfecta type XI identified by clinical exome sequencing.

Velasco H, Morales J Appl Clin Genet. 2017; 10:75-83.

PMID: 29158687 PMC: 5683792. DOI: 10.2147/TACG.S126277.

Osteogenesis imperfecta: clinical diagnosis, nomenclature and severity assessment.

van Dijk F, Sillence D Am J Med Genet A. 2014; 164A(6):1470-81.

PMID: 24715559 PMC: 4314691. DOI: 10.1002/ajmg.a.36545.

Causes of death in osteogenesis imperfecta.

McAllion S, Paterson C J Clin Pathol. 1996; 49(8):627-30.

PMID: 8881910 PMC: 500603. DOI: 10.1136/jcp.49.8.627.

References
1.
Barsh G, David K, Byers P . Type I osteogenesis imperfecta: a nonfunctional allele for pro alpha 1 (I) chains of type I procollagen. Proc Natl Acad Sci U S A. 1982; 79(12):3838-42. PMC: 346523. DOI: 10.1073/pnas.79.12.3838. View
2.
Sillence D, Senn A, Danks D . Genetic heterogeneity in osteogenesis imperfecta. J Med Genet. 1979; 16(2):101-16. PMC: 1012733. DOI: 10.1136/jmg.16.2.101. View
3.
Peltonen L, Palotie A, Prockop D . A defect in the structure of type I procollagen in a patient who had osteogenesis imperfecta: excess mannose in the COOH-terminal propeptide. Proc Natl Acad Sci U S A. 1980; 77(10):6179-83. PMC: 350238. DOI: 10.1073/pnas.77.10.6179. View
4.
Mantel N, Haenszel W . Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959; 22(4):719-48. View
5.
Francis M, Williams K, Sykes B, Smith R . The relative amounts of the collagen chains alpha 1(I), alpha 2 and alpha 1(III) in the skin of 31 patients with osteogenesis imperfecta. Clin Sci (Lond). 1981; 60(6):617-23. DOI: 10.1042/cs0600617. View